Health
Studies Find B7-H3 Protein a Novel, Promising Target for Prostate Cancer Treatments – Newswise
The immune checkpoint protein B7-H3 may be a promising new target for immunotherapy in treatment-resistant prostate cancers,…
Newswise — The immune checkpoint protein B7-H3 may be a promising new target for immunotherapy in treatment-resistant prostate cancers, according to two new studies led by researchers at the Johns Hopkins Kimmel Cancer Center. The studies were presented…
Continue Reading
-
General22 hours agoTrump’s trade team chases 90 deals in 90 days
-
Noosa News16 hours agoTalented new artist on jazz scene
-
General22 hours agoGather Round’s first ever Sicko Saturday treats Adelaide Oval to a day of gloriously bad football
-
General22 hours agoClick-bait Bandt | The Spectator Australia